A Center for Global Development (CGD) paper authored by OHE’s Adrian Towse and CGD’s Rachel Silverman Bonnifield shows a very high expected return on investment (ROI) for a program to incentivise antibiotic development via a US government subscription-based pull mechanism. Proposed legislation (the PASTEUR Act) could make this ROI a reality, saving millions of lives.

We highlight the role pharmaceuticals can play in preventing a climate catastrophe. Pharmaceuticals may make significant contributions to health system carbon footprints, but decarbonisation will be challenging. Progress requires coordinated action by industry, the UK government, and the NHS. Without this, it will not be possible to secure a green era for pharmaceuticals.